Tenet Healthcare jumps as Q1 EPS beat and reaffirmed 2026 outlook drive follow-through bid
THC•Tenet Healthcare shares rose after investors focused on its strong Q1 2026 results, highlighted by adjusted EPS of $4.82 and reaffirmed full-year 2026 outlook. The move also reflects post-earnings follow-through as attention stays on ambulatory growth and capital returns.
1. What’s moving the stock
Tenet Healthcare (THC) is higher in Wednesday trading (May 6, 2026) as the market continues to reprice the name following its late-April earnings update, where the company posted a clear bottom-line beat and reiterated its full-year outlook. A fresh wave of earnings-focused coverage circulated today emphasizing the magnitude of the adjusted EPS upside versus expectations, helping keep momentum pointed higher. (zacks.com)




